Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02603601
Other study ID # 2013P000259
Secondary ID
Status Completed
Phase N/A
First received February 4, 2015
Last updated May 2, 2017
Start date March 2014
Est. completion date October 2014

Study information

Verified date May 2017
Source Beth Israel Deaconess Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized controlled trial is designed to test the feasibility and efficacy of a novel 10-week mindfulness-based intervention (MBI) on weight maintenance as well as behavioral and psychosocial outcomes in patients who have undergone bariatric surgery.

Primary hypothesis:

Bariatric patients who have stopped losing weight (< 5 lbs weight loss in past month) 1-5 years post-surgery will be willing to participate in this 10-week intervention. The investigators expect a high adherence rate (>70%) and no issues with meeting recruitment goals.

Secondary hypotheses:

Patients assigned to the MBI will show greater improvement in a) weight control (defined by differences in body weight between baseline and follow-up); b) eating behaviors (binge eating, emotional eating); and c) psychosocial measures (quality of life, depression, perceived stress, eating self-efficacy, coping ability) than a standard lifestyle intervention (1 hr lifestyle counseling).

Patients assigned to the MBI intervention will show greater improvement in biomarkers of stress and inflammation [salivary cortisol, high sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha)] as compared with a standard lifestyle intervention.

Food-related attentional bias as measured by the food-related Stroop task will be differentially affected among patients assigned to the MBI as compared with the intensive lifestyle intervention and standard lifestyle intervention.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date October 2014
Est. primary completion date October 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

1. Patients who have undergone bariatric surgery 1-5 years prior to study start (by medical record and/or self report)

2. Weight loss plateau (< 5 lbs weight loss in past month) (by medical report and/or self report)

3. Ages 18-65 years (by medical record and/or self report)

4. Able to complete outcome assessments

Exclusion Criteria:

1. Prior experience with meditation course (past 6 months), current mindfulness/meditation practice, or regular meditation or mindfulness practice in past year ("Regular practice" defined as practicing formally 1 or more times a week for 2 months).

2. Plans to leave the study area within next 12 months

3. Serious psychiatric illness or personality disorder (by medical record and/or self-report)

4. Current alcohol and/or substance abuse

5. Pregnancy or plans to become pregnant in next year

6. Non-English speaking

7. > 1 prior weight loss surgery (by medical record and self-report)

8. Gastric band removed prior to study contact.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mind-body lifestyle intervention

Standard lifestyle intervention


Locations

Country Name City State
United States Beth Israel Deaconness Medical Center Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Beth Israel Deaconess Medical Center Center for Nutritional Research Charitable Trust

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Biomarkers of stress measured by bioassay techniques 12 ± 2 weeks
Other Biomarkers of inflammation measured by bioassay techniques 12 ± 2 weeks
Other Food-related attentional bias as measured by the Food-related Stroop task. 12 ± 2 weeks
Primary Success meeting recruitment goals (20 patients within 3-4 months) 4-month recruitment window
Primary Willingness to participate in study (>10% of eligible) 4-month recuitment window
Primary Adherence rate (=70% attendance, 7 of 10 classes) 12-weeks
Primary Retention (=25% drop-out) 6-months
Secondary Changes in body weight as measured on a digital scale 12 ± 2 weeks post intervention-baseline
Secondary Eating behaviors measured using the Three Factor Eating Questionnaire 12 ± 2 weeks
Secondary Eating behaviors measured using the Binge Eating Scale 12 ± 2 weeks
Secondary Quality of life measured using the Medical Outcomes Study Short-Form-36 scale 12 ± 2 weeks
Secondary Quality of life measured using the Impact of Weight on Quality of Life scale 12 ± 2 weeks
Secondary Depression measured by the Center for Epidemiologic Studies Depression Scale 12 ± 2 weeks
Secondary Perceived stress measured by the Perceived Stress Scale 12 ± 2 weeks
Secondary Ability to cope measured by the Brief Cope questionnaire 12 ± 2 weeks
Secondary Eating self-efficacy measured by the Weight Efficacy Lifestyle Questionnaire 12 ± 2 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2